...
首页> 外文期刊>Gut and Liver >Stable Gastric Pentadecapeptide BPC 157, Robert’s Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye’s Stress Coping Response: Progress, Achievements, and the Future
【24h】

Stable Gastric Pentadecapeptide BPC 157, Robert’s Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye’s Stress Coping Response: Progress, Achievements, and the Future

机译:稳定胃五肽肽BPC 157,罗伯特胃细胞保护/适应性细胞保护/有机保护,以及SEYE的压力应对响应:进步,成就和未来

获取原文
           

摘要

We reviewed again the significance of the stable gastric pentadecapeptide BPC 157 as a likely mediator of Robert’s stomach cytoprotection/adaptive cytoprotection and organoprotection and as novel mediator of Selye’s stress coping response to reestablish homeostasis. Specific points of BPC 157 therapy and the original concept of Robert’s cytoprotection/adaptive cytoprotection/organoprotection are discussed, including the beneficial effects of BPC 157. First, BPC 157 protects stomach cells and maintains gastric integrity against various noxious agents (Robert’s killing cell by contact) and is continuously present in the gastric mucosa and gastric juice. Additionally, BPC 157 protects against the adverse effects of alcohol and nonsteroidal anti-inflammatory drugs on the gastric epithelium and other epithelia, that is, skin, liver, pancreas, heart (organoprotection), and brain, thereby suggesting its use in wound healing. Additionally, BPC 157 counteracts gastric endothelial injury that precedes and induces damage to the gastric epithelium and generalizes “gastric endothelial protection” to protection of the endothelium of other vessels (thrombosis, prolonged bleeding, and thrombocytopenia). BPC 157 also has an effect on blood vessels, resulting in vessel recruitment that circumvents vessel occlusion and the development of additional shunting and rapid bypass loops to rapidly reestablish the integrity of blood flow (ischemic/reperfusion colitis, duodenal lesions, cecal perforation, and inferior vena caval occlusion). Lastly, BPC 157 counteracts tumor cachexia, muscle wasting, and increases in pro-inflammatory/procachectic cytokines, such as interleukin-6 and tumor necrosis factor-α, and significantly corrects deranged muscle proliferation and myogenesis through changes in the expression of FoxO3a, p-AKT, p-mTOR, and p-GSK-3β (mitigating cancer cachexia).
机译:我们再次审查了稳定的胃五肽BPC 157作为罗伯特胃细胞保护/适应性细胞保护和有机冲突的可能介质以及Selye的压力应对反应的新介质,以重新建造的重新建造的新介质。讨论了BPC 157治疗的具体点和罗伯特的细胞保护/适应性细胞保护/有机博语的原始概念,包括BPC 157的有益效果。首先,BPC 157保护胃细胞并保持针对各种有害药物的胃直接性(Robert的杀戮细胞通过接触)并且连续存在于胃粘膜和胃液中。此外,BPC 157可防止醇和非甾体抗炎药对胃膜上皮和其他上皮细胞的不利影响,即皮肤,肝脏,胰腺,心脏(有机冲动)和脑,从而表明其在伤口愈合中使用。此外,BPC 157抵消了胃内皮损伤,致胃上皮损伤,并概括了“胃内皮保护”保护其他血管内皮(血栓形成,延长出血和血小板减少)。 BPC 157也对血管产生了影响,导致血管招生,围绕血管闭塞和额外的分流和快速旁路环的发展,以便快速重建血流的完整性(缺血性/再灌注结肠炎,十二指肠病变,肠穿孔和较差腔静脉闭塞)。最后,BPC 157抵消了肿瘤恶病症,肌肉丢失,并增加了促炎/治疗细胞因子,例如白细胞介素-6和肿瘤坏死因子-α,并通过FOXO3A,P表达的变化显着校正Deranged肌肉增殖和肌发发。 -akt,p-mtor和p-gsk-3β(缓解癌症恶毒糖尿病)。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号